Is PZU undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6
Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PZU when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PZU (PLN42.68) is trading below our estimate of fair value (PLN115.8)
Significantly Below Fair Value: PZU is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PZU?
Key metric: As PZU is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for PZU. This is calculated by dividing PZU's market cap by their current
earnings.
What is PZU's PE Ratio?
PE Ratio
7.4x
Earnings
zł4.96b
Market Cap
zł34.50b
PZU key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: PZU is good value based on its Price-To-Earnings Ratio (7.4x) compared to the European Insurance industry average (11.7x).
Price to Earnings Ratio vs Fair Ratio
What is PZU's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
PZU PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
7.4x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PZU's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst PZU forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
zł42.68
zł52.71
+23.5%
12.7%
zł62.20
zł41.30
n/a
10
Nov ’25
zł39.70
zł52.71
+32.8%
12.7%
zł62.20
zł41.30
n/a
10
Oct ’25
zł42.20
zł52.71
+24.9%
12.7%
zł62.20
zł41.30
n/a
10
Sep ’25
zł46.64
zł52.48
+12.5%
12.5%
zł62.20
zł41.30
n/a
10
Aug ’25
zł47.61
zł52.88
+11.1%
12.7%
zł62.20
zł41.30
n/a
10
Jul ’25
zł51.34
zł52.93
+3.1%
12.8%
zł62.20
zł41.30
n/a
10
Jun ’25
zł50.00
zł52.93
+5.9%
12.8%
zł62.20
zł41.30
n/a
10
May ’25
zł51.28
zł52.94
+3.2%
9.9%
zł62.20
zł41.60
n/a
9
Apr ’25
zł48.81
zł51.05
+4.6%
9.2%
zł56.00
zł41.60
n/a
8
Mar ’25
zł49.57
zł50.80
+2.5%
8.8%
zł55.60
zł41.60
n/a
8
Feb ’25
zł48.01
zł50.67
+5.5%
8.7%
zł55.60
zł41.60
n/a
8
Jan ’25
zł47.27
zł50.10
+6.0%
7.7%
zł53.00
zł41.60
n/a
8
Dec ’24
zł46.74
zł45.90
-1.8%
16.9%
zł53.00
zł27.70
n/a
9
Nov ’24
zł47.61
zł45.86
-3.7%
12.0%
zł53.00
zł36.00
zł39.70
8
Oct ’24
zł41.37
zł42.32
+2.3%
12.7%
zł53.00
zł36.00
zł42.20
8
Sep ’24
zł42.24
zł42.04
-0.5%
13.1%
zł53.80
zł36.00
zł46.64
8
Aug ’24
zł40.77
zł39.62
-2.8%
14.3%
zł49.00
zł27.70
zł47.61
9
Jul ’24
zł39.41
zł39.44
+0.07%
14.7%
zł49.00
zł27.70
zł51.34
9
Jun ’24
zł39.63
zł39.44
-0.5%
14.7%
zł49.00
zł27.70
zł50.00
9
May ’24
zł38.30
zł38.54
+0.6%
14.9%
zł49.00
zł27.70
zł51.28
9
Apr ’24
zł35.08
zł37.71
+7.5%
14.9%
zł49.00
zł27.70
zł48.81
9
Mar ’24
zł36.76
zł38.71
+5.3%
12.5%
zł49.00
zł34.00
zł49.57
8
Feb ’24
zł36.67
zł38.55
+5.1%
13.0%
zł49.00
zł33.60
zł48.01
8
Jan ’24
zł35.42
zł38.17
+7.8%
12.7%
zł49.00
zł33.60
zł47.27
8
Dec ’23
zł31.94
zł36.46
+14.2%
14.6%
zł46.90
zł27.70
zł46.74
9
Nov ’23
zł26.80
zł35.95
+34.1%
17.6%
zł46.90
zł27.00
zł47.61
9
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.